Prognosticating poor outcome in COVID-19

Q3 Medicine

Tokai Journal of Experimental and Clinical Medicine Pub Date : 2023-03-18 DOI:10.52142/omujecm.40.1.39

E. Pala

引用次数: 0

Abstract

We have read the article titled “Comparison of liver biomarkers with N/L ratio, CRP, d-dimer in Covid 19 pneumonia and its effect on mortality” prepared by Haydar et al. with great interest. We thank the editorial board and the authors for publishing this successful and informative manuscript. We also would like to mention a few important points about prognosticating mortality in COVID-19 to contribute to the discussion of the study.

查看原文本刊更多论文

预测COVID-19预后不良

我们饶有兴趣地阅读了Haydar等人的文章《Covid - 19肺炎中N/L比值、CRP、d-二聚体肝脏生物标志物的比较及其对死亡率的影响》。我们感谢编委会和作者出版了这篇成功和信息丰富的手稿。我们还想提到关于COVID-19预测死亡率的几个要点，以促进对该研究的讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Tokai Journal of Experimental and Clinical Medicine Medicine-Medicine (all)

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： The Tokai Journal of Experimental and Clinical Medicine, also referred to as Tokai Journal, is an official quarterly publication of the Tokai Medical Association. Tokai Journal publishes original articles that deal with issues of clinical, experimental, socioeconomic, cultural and/or historical importance to medical science and related fields. Manuscripts may be submitted as full-length Original Articles or Brief Communications. Tokai Journal also publishes reviews and symposium proceedings. Articles accepted for publication in Tokai Journal cannot be reproduced elsewhere without written permission from the Tokai Medical Association. In addition, Tokai Journal will not be held responsible for the opinions of the authors expressed in the published articles.